$3.5 Billion Each Year—That's the FTC's conservative estimate of how much this pay-for-delay setup costs consumers and taxpayers.
Stand Up To Big Pharma We all know prescription drugs cost too
much. That’s partly because brand-name drug companies are paying
off generic drug makers to delay competition and keep
prices high. This practice, called “pay for delay,” has been
used by at least eight of the 10 top drug makers.
It's anti-competitive. It's hurting consumers. It has to stop now.
Add Your Voice To The Call To End Pay For DelayDrug companies spend more on lobbying than any other
industry. But if we build enough public support, we can stop the
practice of pay for delay, and bring down drug costs. Send a
message to Congress that they need to stand up for consumers,
and put an end to pay for delay once and for all.
Dear Member of Congress,
Sincerely,[Your Name] [Your Address] [City, State ZIP]
If you take action and have not already registered, you will receive periodic updates and communications.
UNITED STATES PUBLIC INTEREST RESEARCH GROUP
44 Winter Street, 4th Fl. • Boston, MA 02108
FEDERAL ADVOCACY OFFICE:
218 D Street SE, 1st Fl. • Washington, DC 20003